Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026, May 2026 and Jun 2026.
- Largest single sale: $1.6M (85,870 shares) of MoonLake Immunotherapeutics on Apr 9, 2026. Filing
- Last sale before this period: Dec 20, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Apr 15, 2022 | Jun 23, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 22, 2026, MoonLake Immunotherapeutics: sold 39,120 shares for $862K, under a disclosed plan. 1 filing: 1
- Jun 18, 2026, MoonLake Immunotherapeutics: sold 2,794 shares for $55K, under a disclosed plan. 1 filing: 1
- Jun 17, 2026, MoonLake Immunotherapeutics: sold 15,082 shares for $297K, under a disclosed plan. 1 filing: 1
- May 11, 2026, MoonLake Immunotherapeutics: sold 13,653 shares for $273K, under a disclosed plan. 1 filing: 1
- Apr 14, 2026, MoonLake Immunotherapeutics: sold 2,426 shares for $47K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.